humburger_img menu_close_icon

Anti-Inflammatory Tripeptide

KPV 10mg

Derived from alpha-MSH for inflammation support

KPV is a naturally occurring tripeptide fragment of alpha-melanocyte stimulating hormone (α-MSH) that powerfully modulates inflammatory responses throughout the body. By targeting key inflammatory pathways, KPV supports tissue healing, reduces chronic inflammation, and promotes gut health through its unique anti-inflammatory and antimicrobial properties.

10mg

Therapeutic Dosage

SC/IM

Administration

1-2x

Daily Dosing

4-8

Week Cycles

KPV Protocol

Physician-prescribed anti-inflammatory therapy with comprehensive medical oversight and personalized dosing strategies.

What is KPV?

KPV is a tripeptide consisting of three amino acids (lysine-proline-valine) naturally derived from alpha-melanocyte stimulating hormone (α-MSH), a critical immune-regulating peptide in the body. This small but powerful peptide plays a vital role in controlling inflammation by modulating key inflammatory pathways and inhibiting pro-inflammatory signaling cascades.

Unlike conventional anti-inflammatory drugs that suppress the entire immune system, KPV works intelligently by targeting specific inflammatory mediators. It inhibits pro-inflammatory cytokines while preserving beneficial immune responses, making it particularly effective for chronic inflammatory conditions where targeted inflammation control is essential.

Research has demonstrated KPV’s remarkable efficacy in supporting gut health, particularly in inflammatory bowel conditions such as ulcerative colitis and Crohn’s disease. The peptide exhibits both anti-inflammatory and antimicrobial properties, helping to restore intestinal barrier function, reduce mucosal inflammation, and promote healing of damaged gut tissue. Additionally, KPV has shown promise in managing skin inflammation, wound healing, and systemic inflammatory conditions by modulating immune responses at the cellular level.

Book a Consultation

Mechanism of Action

KPV reduces inflammation through multiple pathways that target pro-inflammatory signaling while supporting tissue healing and immune balance.

NF-κB Inhibition

Directly inhibits nuclear factor kappa B (NF-κB), a master regulator of inflammatory gene expression, preventing production of pro-inflammatory cytokines like TNF-α and IL-6.

Antimicrobial Activity

Exhibits broad-spectrum antimicrobial properties against pathogenic bacteria and biofilms, helping to rebalance gut microbiota and reduce inflammatory triggers from dysbiosis.

Mucosal Healing

Promotes intestinal barrier integrity and mucosal tissue repair by reducing inflammation at the gut lining, supporting tight junction function and healing damaged epithelial cells.

Why Consider KPV?

Inflammatory Bowel Support

Clinically studied for reducing inflammation in ulcerative colitis and Crohn’s disease, helping to calm inflamed intestinal tissue and support remission.

Gut Barrier Restoration

Promotes intestinal barrier function by supporting tight junction integrity, reducing intestinal permeability (“leaky gut”), and enhancing mucosal defense mechanisms.

Reduced Systemic Inflammation

Modulates inflammatory cytokines throughout the body, helping to reduce chronic low-grade inflammation associated with metabolic disorders and aging.

Antimicrobial Properties

Exhibits natural antimicrobial activity against pathogenic bacteria, biofilms, and harmful microorganisms, supporting a healthier gut microbiome balance.

Skin & Wound Healing

Supports dermatological healing by reducing skin inflammation, promoting tissue repair, and addressing inflammatory skin conditions like eczema and psoriasis.

Autoimmune Modulation

Helps regulate overactive immune responses in autoimmune conditions by balancing inflammatory pathways without broadly suppressing immune function.

How It Works at BHRC

Our medical team guides you through every step—from initial consultation to ongoing optimization.

Medical Consultation

Comprehensive evaluation of inflammatory conditions, gut health concerns, and treatment objectives.

Diagnostic Assessment

Complete inflammatory markers, gut health testing, and baseline labs to assess condition severity and guide protocol design.

Custom Protocol

Receive personalized KPV dosing regimen based on your inflammatory profile, symptoms, and therapeutic goals.

Ongoing Monitoring

Regular follow-ups with symptom tracking, inflammatory marker testing, and protocol adjustments for optimal inflammation control.

Is KPV Right for You?

KPV has demonstrated an excellent safety profile in clinical research and therapeutic use. Our medical team evaluates each patient individually to ensure appropriate candidacy and optimal dosing strategies.

  • Well-Tolerated — Most patients experience no adverse effects; KPV is generally very well-tolerated with minimal side effects reported.
  • Targeted Action — Unlike broad immunosuppressants, KPV selectively targets inflammatory pathways without compromising overall immune function.
  • Bioidentical Peptide — Derived from naturally occurring α-MSH, KPV is recognized by the body as a bioidentical compound with excellent biocompatibility.
  • Medical Oversight — All therapy is physician-supervised with regular monitoring to ensure safety, efficacy, and proper dose optimization.
Speak With a Physician

20+

Years of research demonstrating safety and anti-inflammatory efficacy

95%+

Patient tolerability rate with excellent safety profile

Frequently Asked

KPV works by inhibiting nuclear factor kappa B (NF-κB), a master regulator of inflammatory gene expression. By blocking NF-κB activation, KPV prevents the production of pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1β. This targeted approach reduces inflammation at the source without broadly suppressing the immune system. KPV also exhibits antimicrobial properties that help address inflammatory triggers from pathogenic bacteria, particularly in the gut.

KPV has been clinically studied for inflammatory bowel diseases (ulcerative colitis, Crohn’s disease), leaky gut syndrome, chronic inflammatory conditions, autoimmune disorders, skin inflammation (eczema, psoriasis), and wound healing. It’s particularly effective for gut-related inflammation due to its direct effects on intestinal barrier function and mucosal healing. Your BHRC physician will assess whether KPV is appropriate for your specific inflammatory condition.

KPV is administered via subcutaneous or intramuscular injection, typically at doses ranging from 200-500mcg per injection. Most protocols involve 1-2 daily injections depending on the severity of inflammation and individual response. Some patients may use KPV in cycles of 4-8 weeks, while others with chronic conditions may benefit from longer-term use. Your physician will design a personalized dosing protocol based on your specific needs and inflammatory markers.

Response times vary based on the condition being treated and individual factors. Some patients report reduced inflammatory symptoms within 1-2 weeks of consistent use. For gut-related conditions, noticeable improvements in digestive symptoms, bowel regularity, and abdominal discomfort often occur within 2-4 weeks. Measurable changes in inflammatory markers typically appear within 4-6 weeks. Long-term benefits, including sustained inflammation reduction and tissue healing, develop over 8-12 weeks of therapy.

KPV has an excellent safety profile with minimal reported side effects. Occasional mild injection site reactions (redness, tenderness) may occur. Unlike systemic immunosuppressants, KPV does not broadly suppress immune function. However, individuals with active infections should consult with their physician before starting therapy. Comprehensive medical evaluation ensures safe and appropriate use. There are no known significant drug interactions, but full disclosure of medications is essential during your consultation.

Yes, KPV can be safely combined with other peptide therapies, gut healing protocols, and anti-inflammatory interventions. Many patients use KPV alongside BPC-157 for enhanced gut healing, with other immune-modulating peptides, or as part of comprehensive inflammatory management programs. KPV is generally compatible with conventional medications, but your BHRC physician will review all current treatments to design an integrated protocol optimized for your specific condition.

KPV peptide therapy is typically not covered by insurance as it’s considered preventive and regenerative medicine. BHRC offers transparent pricing and flexible payment options to make this innovative therapy accessible. Many patients find the investment worthwhile given the significant impact on inflammatory control and overall quality of life. Our team can provide detailed cost information and discuss payment plans during your consultation.

Begin Your Transformation

Schedule a consultation with our medical team to learn if KPV peptide therapy is right for your wellness journey.

"*" indicates required fields

This field is hidden when viewing the form
Terms*
I Consent to Receive SMS and Email Notifications, Alerts & Occasional Marketing Communication from BHRC. Message Frequency Varies. Message & Data Rates May Apply. You Can Reply STOP to Unsubscribe from SMS at Any Time.

Or call us directly: +1 213-325-3373

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. KPV is provided for anti-inflammatory support and wellness purposes under physician supervision. Individual results may vary. A consultation with our medical team and baseline laboratory testing are required to determine if this therapy is appropriate for you.

22 Locations in California, Nevada, Texas, and Arizona

Beverly Hills Rejuvenation
Center Locations

Find Nearest Location